Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit
The DOI matches its Crossref record.
Abstract
BACKGROUND: This proof of concept study was designed to evaluate the safety and effectiveness of an intravenous insulin dosing calculator, the Clarian GlucoStabilizer program, and to determine the feasibility of its use as part of a glycemic control program. This paper discusses the impact of the GlucoStabilizer program on the glycemic control of intensive care patients with hyperglycemia. METHODS: Patients admitted to the intensive care unit (ICU), requiring intravenous insulin, were treated using the GlucoStabilizer program. This program calculates an insulin drip rate based on the low and high blood glucose (BG) levels of the desired target range, the patient's current and previous BG levels, and an insulin sensitivity factor, with a goal of safely and expeditiously achieving and maintaining the patient's BG in the target range. RESULTS: From October 2004 through March 2006, the GlucoStabilizer program has been used to treat 2,398 patients in the ICUs, with 177,279 BG measurements in its database. In these patients, 61.0% of BGs have been in the target range of 80-110 mg/dL, while 90.9% have been in the wider range of 60-150 mg/dL. The average BG was 106.5 mg/dL (SD 39.1 mg/dL), and the frequency of hypoglycemia (BG <50 mg/dL) was 0.4%. These results compare favorably with the level of glycemic control in the 3 months before implementation of the GlucoStabilizer program. CONCLUSIONS: Use of the GlucoStabilizer program in the ICU resulted in improved glycemic control compared to the previous manually calculated glycemic control protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 15
- 10.1172/JCI25385 · DOI · Paper page
- 10.1161/01.CIR.0000121747.71054.79 · DOI · Paper page
- 10.4065/79.8.992 · DOI · Paper page
- 10.1016/S0003-4975(99)00014-4 · DOI · Paper page
- 10.1056/NEJMoa011300 · DOI · Paper page
- 10.1016/S0003-4975(96)01044-2 · DOI · Paper page
- Garber AJ, 2004, Endocr Pract, 10, 4, 10.4158/EP.10.S2.4 · DOI · Paper page
- 10.1592/phco.26.2.214 · DOI
- 10.2337/diacare.29.02.06.dc05-1689 · DOI · Paper page
- 10.2337/diacare.28.10.2418 · DOI · Paper page
- 10.1111/j.1365-2044.2005.04375.x · DOI
- 10.1089/dia.2005.7.937 · DOI
- 10.1089/152091504774198016 · DOI
- 10.7326/0003-4819-97-2-210 · DOI · Paper page
- Davidson PC, 1986, Diabetes, 35, A126
Cited by
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Jacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Lazar, H. L., McDonnell, M., Chipkin, S. R., Furnary, A. P., Engelman, R. M., Sadhu, A. R., Bridges, C. R., Haan, C. K., Svedjeholm, R., Taegtmeyer, H., et al. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.11.011 · Cited by 490
Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review
Kansagara, D., Fu, R., Freeman, M., Wolf, F., & Helfand, M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00008 · Cited by 255
Juneja, R., Roudebush, C. P., Nasraway, S. A., Golas, A. A., Jacobi, J., Carroll, J., Nelson, D., Abad, V. J., & Flanders, S. J. (2009) · Critical Care · doi:10.1186/cc8129 · Cited by 86
“Use of the GlucoStabilizer has been previously described in detail [29].”
BackgroundMethodSelf-citationNewton, C. A., Smiley, D., Bode, B. W., Kitabchi, A. E., Davidson, P. C., Jacobs, S., Steed, R. D., Stentz, F., Peng, L., Mulligan, P., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.816 · Cited by 84
“13,14 It is not known, however, if computer-based algorithms are superior to standard paper form-based protocols in achieving glucose control and in reducing hypoglycemic events in critically-ill patients.”
Aloi, J., Bode, B. W., Ullal, J., Chidester, P., McFarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816664746 · Cited by 39
Saur, N. M., Kongable, G. L., Holewinski, S., O’Brien, K., & Nasraway, S. A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.07.003 · Cited by 37
Temporal occurrences and recurrence patterns of hypoglycemia during hospitalization
Ulmer, B. J., Kara, A., & Mariash, C. N. (2015) · Endocrine Practice · doi:10.4158/ep14355.or · Cited by 28
Tanenberg, R. J., Hardee, S., Rothermel, C., & Drake, A. J. (2017) · Endocrine Practice · doi:10.4158/ep161402.or · Cited by 27
Mader, J. K., Motschnig, M., Theiler-Schwetz, V., Eibel-Reisz, K., Reisinger, A. C., Lackner, B., Augustin, T., Eller, P., & Mirth, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0082 · Cited by 4
Metadata
- Authors
- Juneja, R., Roudebush, C., Kumar, N., Macy, A., Golas, A., Wall, D., Wolverton, C., Nelson, D., Carroll, J., & Flanders, S. J.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2007-06
- Volume
- 9
- Issue
- 3
- Pages
- 232-240
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1965913104
- Cited by
- 113
- References
- 0
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.